EPIRUS Biopharmaceuticals initiates pivotal hlobal Phase 3 clinical study for BOW015 (Infliximab biosimilar).
Boehringer Ingelheim’s Gilotrif to gain ground in non-small cell lung cancer markets outside the U.S., says GlobalData.
A new study found that while the Tdap booster vaccine provides moderate protection against whooping cough during the first year after vaccination, its effectiveness wanes over time.
Researchers at Umea University in Sweden help assess the risk that Zika will spread to Europe by describing the transmission season, areas at risk, and intervention strategies.
U. Iowa team shows how protein analysis can make diagnoses more accurate and treatments better targeted to individual patients.
CytRx Corporation has entered into a long-term loan and security agreement for up to $40 million in financing.
A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing.
Johnson & Johnson and privately held ViaCyte, Inc. are joining forces to speed development of a Type 1 diabetes cure.
International Business Systems’ approach to ERP systems in light of the DSCSA requirements.